Chemfab Alkalis Q2 FY27 Performance Update and Expansion Roadmap
Chemfab Alkalis Ltd · Investor Presentation · 29 Oct 2026, 4:14 am
Chemfab Alkalis Q2 FY27 Performance Update and Expansion Roadmap Chemfab Alkalis reported consolidated revenue from operations of ₹75.61 crore in Q2 FY27, down 1.24% YoY (+3.35% QoQ), with operational EBITDA declining 30.50% QoQ to ₹7.04 crore (9.31% margin) and a PBT loss of ₹2.95 crore. Chemical segment ECU realizations softened to ₹38,000/MT, while the OPVC segment posted revenue of ₹6.39 crore. Management anticipates stronger consolidated performance in H2 FY27 driven by stabilizing caustic prices, cost-efficiency projects, and expanding Sri City OPVC pipe capacity to 23,000 TPA by Q4 FY27 to capture government infrastructure demand.
Original exchange filing (PDF)
More announcements from Chemfab Alkalis Ltd
- Chemfab Alkalis Limited has informed the Exchange regarding changes In Designations In Composition Of The Stakeholders Relationship Committee · 28 Oct 2026
- Submission of letter for Changes in designations in Stakeholder Relationship Committee · 29 Oct 2026
- Chemfab Alkalis Limited has informed the Exchange regarding Outcome of Board Meeting held on October 28, 2026 wrt approval by board in designating Chief Operating Officer (Senior Management Personnel) · 28 Oct 2026
- Chemfab Alkalis Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 28 Oct 2026
- Submission of approval by the Board wrt. designating Chief Operating Officer (Senior Management Personnel) in the Company at its meeting held on 28th October 2026 · 29 Oct 2026
- Submission of Unaudited financial results for quarter and half year ended 30th September 2026 · 29 Oct 2026
- In the Board meeting held today i.e., 28th October, 2026, the Board has approved Un-Audited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September 2026 · 29 Oct 2026
- Chemfab Alkalis Limited has informed the Exchange about Board Meeting to be held on 28-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 28 Oct 2026
